Carbon dots for reactive oxygen species modulation

Reactive oxygen species (ROS) manipulation is emerging as a pivotal focus in biomaterials design. Carbon dots (CDs), with their superior biocompatibility, facile synthesis, exceptional electronic properties, and abundant active sites, are gaining significant attention as ROS modulators (CDRMs). However, unclear mechanisms of action and challenges in controlling activity and selectivity hinder the advancement of CDRMs for sophisticated biomedical applications. While existing reviews have summarized the synthesis and biomedical applications of CDs, none have systematically addressed their roles and mechanisms in ROS modulation. Additionally, a universal principle for designing efficient and selective CDRMs is urgently needed to advance their clinical translation. This review explores the origins of activity in CDRMs, elucidates modulation mechanisms, and provides in-depth insights into tailoring CDRMs for ROS upregulation, downregulation, and bidirectional manipulation. Strategies such as nanozyme-catalyzed, physical field-energized, and precursor-inherited ROS management are highlighted, followed by an analysis of methods to optimize CDRM activity and selectivity, addressing critical gaps in current literature. Furthermore, the applications of CDRMs in cancer therapy, wound healing, and inflammation-related diseases are summarized and analyzed. Finally, we discuss existing obstacles, such as low efficacy and selectivity, and propose strategies to enhance the clinical translation of CDRMs, offering a forward-looking perspective to guide future research and innovation in this promising field. © 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.